ArticleScientific reports2025
Thyroid function test profile in patients who have thyroid nodule and its correlation with ultrasound TIRAD scoring system and cytological results.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hashimoto's thyroiditis in an Egyptian cohort: clinical, functional, and ultrasonographic features with insights into nodule risk.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid nodules are common, as they are found in up to 8% of adults. These nodules are becoming increasingly prevalent, possibly because of the increased use of ultrasound imaging. These nodules are mostly benign but remain a source of concern for both physicians and patients due to the possibility of malignant transformation. The aim of this study was to assess the ability and usefulness of thyroid function tests in predicting ultrasound and FNA outcomes of thyroid nodules and therefore confirm or rule out the malignant potential of these nodules. In this case‒control, prospective study, one hundred patients who presented to the outpatient clinic from March 2022 to June 2024 for evaluation of thyroid nodules were included. Follow-up protocols included medical history review, physical examination, thyroid function tests, ultrasound imaging examination and fine needle aspiration if indicated. Data were analyzed using SPSS 25, and a p value less than 0.05 indicated statistical significance. 40% of patients who had thyroid nodules had normal thyroid function tests, 28% had subclinical hyperthyroidism, 22% had subclinical hypothyroidism, 8% had overt hypothyroidism according to laboratory findings, and 2% had overt hyperthyroidism according to laboratory findings. A higher-than-normal BMI was significantly associated with TIRADS 2 nodules (95% C. I 0.40-0.97, p value < 0.0001), and a low BMI was significantly associated with TIRADS 4 nodules (95% C. I 0.08-0.53, p value 0.04). High levels of TSH were significantly associated with TIRADS 2 nodules (95% C. I 0.52_1.11, p value < 0.0001), and low levels of TSH, despite normal T3 and T4 levels, were correlated with TIRADS 4 nodules (95% C. I -1.10_0.9, p value < 0.0001). Low levels of TSH, despite normal T3 and T4 levels, and cytological findings were associated with Bethesda 2 nodules, which are benign follicular neoplasms (95% c. I 1.08-1.44, p value < 0.0001. Most patients who had thyroid nodules had normal thyroid function tests; however, low TSH levels were significantly associated with ultrasound evidence of TIRAD 4 nodules and Bethesda 2 nodules according to FNA, and high TSH levels were significantly associated with ultrasound evidence of TIRADS 2 nodules.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.